Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Prognostic Value of End of Treatment FDG-PET Scan in T-Cell Lymphoma, a 20-Year Single Institution Study

Enrico Derenzini, MD PhD, Angela Gueli, MD, Safaa Ramadan, PhD MD, Anna Vanazzi, MD, Simona Sammassimo, MD, Federica Gigli, MD, Niccolo' Frungillo, MD, Riccardo Bruna, MD, Alberto Agazzi, MD, Alberto De Crescenzo, MD, Rocco Pastano, MD, Laura L Travaini, MD, Chiara Grana, MD, Laszlo Daniele, MD, William Arcese, Corrado Tarella, MD

Blood (2016) 128 (22): 3003.

https://doi.org/10.1182/blood.V128.22.3003.3003

Published: 2016

Journal Articles

Unmanipulated, G-CSF Mobilized Peripheral Blood Stem Cells As Graft Source for Non-Myeloablative Haploidentical Transplantation: Fast Engraftment, No Evidence of Graft Rejection, and Low Incidence of Graft-Versus-Host Disease

Rocco Pastano, MD, Giovanna Andreola, MD, Federica Gigli, MD, Simona Sammassimo, MD, Mara Negri, Liptrott Jayne Sarah, Corrado Tarella, MD

Blood (2015) 126 (23): 1924.

https://doi.org/10.1182/blood.V126.23.1924.1924

Published: 2015

Journal Articles

Improved Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Metastatic Renal Cancer Associated with Homozygosity for the HLA-G 14 Base-Pair Deletion Polymorphism: An EBMT STWP Study

Benedetta Mazzi, BSc, Roberto Crocchiolo, MD, Didier Blaise, MD, Lisbeth Barkholt, MD, Jacques-Olivier Bay, MD, PhD, Rocco Pastano, MD, Margherita Torchio, PhD, Stefania Trinca, DM, Jacopo Peccatori, MD, Fabio Ciceri, MD, Katharina Fleischhauer, MD, Marco Bregni, MD

Blood (2012) 120 (21): 4667.

https://doi.org/10.1182/blood.V120.21.4667.4667

Published: 2012

Journal Articles

Valganciclovir Is Safe and Effective as Pre-Emptive Treatment for CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation.

Rocco Pastano, MD, Federica Gigli, MD, Giovanna Andreola, MD, Liliana Calabrese, DM, Fedro Peccatori, MD, Giovanni Martinelli, MD

Blood (2006) 108 (11): 5300.

https://doi.org/10.1182/blood.V108.11.5300.5300

Published: 2006

Journal Articles

Graft-Versus-Lymphoma Effect in Hodgkin’s Disease: A Possible Role in Maintaining a Disease Control.

Rocco Pastano, MD, Giovanna Andreola, MD, Federica Gigli, MD, Luca Saronni, Maria C. Cassatella, Fedro Peccatori, MD, Giovanni Martinelli, MD

Blood (2005) 106 (11): 5423.

https://doi.org/10.1182/blood.V106.11.5423.5423

Published: 2005

Journal Articles

Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation in Renal Cell Carcinoma: The EIO Experience.

Rocco Pastano, MD, Daniele Laszlo, MD, Giovanna Andreola, MD, Federica Gigli, MD, Cristina Rabascio, Valentina Raia, Manuela Cazzanti, Fedro Peccatori, MD, Giovanni Martinelli, MD

Blood (2005) 106 (11): 5424.

https://doi.org/10.1182/blood.V106.11.5424.5424

Published: 2005

Journal Articles

Tumor Control Achieved Despite Loss of Chimaerism in Renal Cell Carcinoma (RCC) Following Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Case Report.

Giovanna Andreola, MD, Federica Gigli, MD, Cristina Rabascio, Manuela Cazzanti, Fedro Peccatori, MD, Saverio Cinieri, MD, Rocco Pastano, MD, Giovanni Martinelli, MD

Blood (2005) 106 (11): 5401.

https://doi.org/10.1182/blood.V106.11.5401.5401

Published: 2005

NARROW

Prognostic Value of End of Treatment FDG-PET Scan in T-Cell Lymphoma, a 20-Year Single Institution Study

Unmanipulated, G-CSF Mobilized Peripheral Blood Stem Cells As Graft Source for Non-Myeloablative Haploidentical Transplantation: Fast Engraftment, No Evidence of Graft Rejection, and Low Incidence of Graft-Versus-Host Disease

Improved Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Metastatic Renal Cancer Associated with Homozygosity for the HLA-G 14 Base-Pair Deletion Polymorphism: An EBMT STWP Study

Valganciclovir Is Safe and Effective as Pre-Emptive Treatment for CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation.

Graft-Versus-Lymphoma Effect in Hodgkin’s Disease: A Possible Role in Maintaining a Disease Control.

Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation in Renal Cell Carcinoma: The EIO Experience.

Tumor Control Achieved Despite Loss of Chimaerism in Renal Cell Carcinoma (RCC) Following Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Case Report.

Email alerts

ASH Publications

American Society of Hematology

Prognostic Value of End of Treatment FDG-PET Scan in T-Cell Lymphoma, a 20-Year Single Institution Study

Unmanipulated, G-CSF Mobilized Peripheral Blood Stem Cells As Graft Source for Non-Myeloablative Haploidentical Transplantation: Fast Engraftment, No Evidence of Graft Rejection, and Low Incidence of Graft-Versus-Host Disease

Improved Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Metastatic Renal Cancer Associated with Homozygosity for the HLA-G 14 Base-Pair Deletion Polymorphism: An EBMT STWP Study

Valganciclovir Is Safe and Effective as Pre-Emptive Treatment for CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation.

Graft-Versus-Lymphoma Effect in Hodgkin’s Disease: A Possible Role in Maintaining a Disease Control.

Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation in Renal Cell Carcinoma: The EIO Experience.

Tumor Control Achieved Despite Loss of Chimaerism in Renal Cell Carcinoma (RCC) Following Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Case Report.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only